AI MARKET SCANNING

$REGN.RTH

Regeneron Pharmaceuticals Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Oct 28, 2026 ☀️ Open🌐 Website🏛️ US Composite📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP-0.31%
MAX GAP RECORD-8.04%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $REGN.RTH

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL